| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 62 | 2024 | 2171 | 3.500 |
Why?
|
| Arthritis, Rheumatoid | 47 | 2016 | 3781 | 1.720 |
Why?
|
| Lyme Disease | 15 | 2021 | 630 | 1.530 |
Why?
|
| Rheumatology | 21 | 2021 | 617 | 1.120 |
Why?
|
| Health Status Indicators | 10 | 2008 | 969 | 0.860 |
Why?
|
| Lithium | 3 | 2023 | 600 | 0.830 |
Why?
|
| Rheumatic Diseases | 18 | 2008 | 659 | 0.770 |
Why?
|
| Antirheumatic Agents | 11 | 2016 | 1381 | 0.700 |
Why?
|
| Arthritis | 15 | 2009 | 684 | 0.670 |
Why?
|
| Osteoarthritis | 21 | 2004 | 1072 | 0.620 |
Why?
|
| Spinal Stenosis | 9 | 1997 | 259 | 0.560 |
Why?
|
| Hip Prosthesis | 14 | 1997 | 924 | 0.510 |
Why?
|
| Arteriosclerosis | 3 | 2005 | 1055 | 0.490 |
Why?
|
| Fatigue | 7 | 2016 | 1557 | 0.480 |
Why?
|
| Sickness Impact Profile | 11 | 2017 | 299 | 0.480 |
Why?
|
| Burns | 11 | 2018 | 1899 | 0.470 |
Why?
|
| Musculoskeletal Diseases | 8 | 2004 | 599 | 0.470 |
Why?
|
| Suicide | 2 | 2023 | 1606 | 0.460 |
Why?
|
| Patient Care | 2 | 2011 | 629 | 0.430 |
Why?
|
| Glucocorticoids | 4 | 2015 | 2167 | 0.410 |
Why?
|
| Activities of Daily Living | 18 | 2002 | 2430 | 0.400 |
Why?
|
| Laminectomy | 6 | 1997 | 226 | 0.390 |
Why?
|
| Patient Selection | 6 | 2014 | 4260 | 0.390 |
Why?
|
| Disability Evaluation | 11 | 2008 | 1835 | 0.390 |
Why?
|
| Patient Education as Topic | 9 | 2012 | 2337 | 0.390 |
Why?
|
| Ticks | 3 | 2007 | 71 | 0.380 |
Why?
|
| Health Status | 21 | 2013 | 4091 | 0.370 |
Why?
|
| Clinical Trials as Topic | 14 | 2016 | 8054 | 0.370 |
Why?
|
| Immunologic Factors | 3 | 2010 | 1596 | 0.360 |
Why?
|
| Physician-Patient Relations | 4 | 2023 | 3269 | 0.360 |
Why?
|
| Humans | 263 | 2024 | 768166 | 0.340 |
Why?
|
| Carpal Tunnel Syndrome | 5 | 1997 | 304 | 0.320 |
Why?
|
| Internet | 3 | 2014 | 3110 | 0.310 |
Why?
|
| Primary Prevention | 4 | 2016 | 1188 | 0.310 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 3415 | 0.300 |
Why?
|
| Autoantibodies | 3 | 2007 | 2121 | 0.300 |
Why?
|
| Severity of Illness Index | 27 | 2017 | 15948 | 0.300 |
Why?
|
| Spondylarthropathies | 1 | 2007 | 14 | 0.300 |
Why?
|
| Arthroplasty, Replacement, Hip | 7 | 2023 | 1417 | 0.290 |
Why?
|
| Osteoarthritis, Knee | 2 | 2010 | 1251 | 0.290 |
Why?
|
| Quality of Life | 28 | 2017 | 13490 | 0.290 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 8 | 2009 | 2271 | 0.280 |
Why?
|
| Mass Screening | 4 | 2014 | 5458 | 0.270 |
Why?
|
| Rheumatoid Factor | 1 | 2007 | 185 | 0.270 |
Why?
|
| Exercise Therapy | 3 | 2003 | 939 | 0.260 |
Why?
|
| Connective Tissue Diseases | 5 | 1999 | 285 | 0.260 |
Why?
|
| Silicones | 3 | 1999 | 228 | 0.260 |
Why?
|
| Administrative Personnel | 1 | 2007 | 185 | 0.260 |
Why?
|
| Knee Injuries | 1 | 2010 | 495 | 0.250 |
Why?
|
| Risperidone | 3 | 2014 | 383 | 0.250 |
Why?
|
| Female | 155 | 2024 | 397192 | 0.250 |
Why?
|
| Middle Aged | 116 | 2022 | 223492 | 0.240 |
Why?
|
| Peptides, Cyclic | 1 | 2007 | 391 | 0.240 |
Why?
|
| Back Pain | 5 | 2008 | 548 | 0.240 |
Why?
|
| Patient Advocacy | 1 | 2007 | 362 | 0.240 |
Why?
|
| Psychometrics | 14 | 2016 | 3063 | 0.240 |
Why?
|
| Male | 134 | 2023 | 364719 | 0.240 |
Why?
|
| Decision Making | 5 | 2019 | 3953 | 0.240 |
Why?
|
| Back Injuries | 2 | 1997 | 41 | 0.240 |
Why?
|
| Myositis | 2 | 2017 | 269 | 0.230 |
Why?
|
| Knee Prosthesis | 7 | 1997 | 395 | 0.230 |
Why?
|
| Patient Participation | 3 | 2014 | 1447 | 0.230 |
Why?
|
| Neurology | 3 | 2021 | 786 | 0.230 |
Why?
|
| Geriatric Assessment | 4 | 1999 | 1422 | 0.230 |
Why?
|
| Misoprostol | 2 | 1996 | 94 | 0.230 |
Why?
|
| Relaxation Therapy | 2 | 2010 | 181 | 0.220 |
Why?
|
| Health Education | 4 | 1997 | 1059 | 0.220 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 2 | 2003 | 32 | 0.220 |
Why?
|
| Health Facility Environment | 1 | 2003 | 32 | 0.220 |
Why?
|
| Physical Examination | 8 | 2000 | 1263 | 0.220 |
Why?
|
| Patient Dropouts | 1 | 2005 | 411 | 0.210 |
Why?
|
| Concurrent Review | 1 | 2002 | 13 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 4 | 2020 | 7454 | 0.210 |
Why?
|
| Los Angeles | 1 | 2023 | 245 | 0.210 |
Why?
|
| Adult | 87 | 2023 | 223646 | 0.210 |
Why?
|
| Communicable Diseases | 2 | 2021 | 874 | 0.200 |
Why?
|
| Treatment Refusal | 1 | 2005 | 433 | 0.200 |
Why?
|
| Osteoarthritis, Hip | 2 | 2023 | 409 | 0.200 |
Why?
|
| Health Behavior | 3 | 2007 | 2650 | 0.200 |
Why?
|
| Delivery of Health Care | 4 | 2018 | 5367 | 0.190 |
Why?
|
| Prednisolone | 1 | 2003 | 326 | 0.190 |
Why?
|
| Rare Diseases | 1 | 2007 | 631 | 0.190 |
Why?
|
| Databases, Factual | 4 | 2017 | 8080 | 0.190 |
Why?
|
| Burn Units | 3 | 2018 | 143 | 0.180 |
Why?
|
| Personality | 2 | 2008 | 559 | 0.180 |
Why?
|
| Sensitivity and Specificity | 21 | 2017 | 14729 | 0.180 |
Why?
|
| Isoenzymes | 2 | 2003 | 1688 | 0.180 |
Why?
|
| Aged | 81 | 2014 | 171504 | 0.180 |
Why?
|
| Health Services Misuse | 1 | 2002 | 246 | 0.180 |
Why?
|
| Terminology as Topic | 5 | 2007 | 1542 | 0.180 |
Why?
|
| Erythema Chronicum Migrans | 1 | 2020 | 48 | 0.180 |
Why?
|
| Societies, Medical | 11 | 2020 | 3968 | 0.180 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2020 | 50 | 0.170 |
Why?
|
| Nervous System Diseases | 4 | 2007 | 1662 | 0.170 |
Why?
|
| Health Services Research | 4 | 2002 | 1815 | 0.170 |
Why?
|
| Anti-Ulcer Agents | 2 | 2003 | 112 | 0.170 |
Why?
|
| Early Diagnosis | 1 | 2005 | 1194 | 0.170 |
Why?
|
| Athletic Injuries | 1 | 2010 | 1245 | 0.170 |
Why?
|
| Bicycling | 2 | 2019 | 177 | 0.170 |
Why?
|
| Disease Management | 4 | 2018 | 2536 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2023 | 10399 | 0.170 |
Why?
|
| Risk Factors | 36 | 2024 | 74944 | 0.170 |
Why?
|
| Research Design | 10 | 2015 | 6211 | 0.170 |
Why?
|
| Knee Joint | 5 | 2010 | 1683 | 0.170 |
Why?
|
| Semantics | 1 | 2003 | 618 | 0.160 |
Why?
|
| United States | 34 | 2024 | 73039 | 0.160 |
Why?
|
| Evaluation Studies as Topic | 13 | 2003 | 1627 | 0.160 |
Why?
|
| Spinal Diseases | 3 | 1994 | 561 | 0.160 |
Why?
|
| Breast Implants | 3 | 2001 | 414 | 0.160 |
Why?
|
| Hospitals, Teaching | 2 | 2002 | 1157 | 0.160 |
Why?
|
| Population Surveillance | 4 | 2012 | 2596 | 0.160 |
Why?
|
| Lumbar Vertebrae | 3 | 1997 | 1885 | 0.150 |
Why?
|
| Joint Prosthesis | 4 | 1997 | 251 | 0.150 |
Why?
|
| Survivors | 3 | 2017 | 2381 | 0.150 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 1999 | 187 | 0.150 |
Why?
|
| Health Care Costs | 5 | 2015 | 3239 | 0.140 |
Why?
|
| Cognition Disorders | 6 | 2016 | 3980 | 0.140 |
Why?
|
| Health Surveys | 7 | 2010 | 4057 | 0.140 |
Why?
|
| Arthroplasty, Replacement, Knee | 4 | 2002 | 1389 | 0.140 |
Why?
|
| Postal Service | 1 | 1997 | 96 | 0.140 |
Why?
|
| Cost-Benefit Analysis | 9 | 2010 | 5536 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 3 | 2020 | 7477 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2015 | 3231 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2010 | 4055 | 0.140 |
Why?
|
| Hospitalization | 6 | 2014 | 10840 | 0.140 |
Why?
|
| Needs Assessment | 1 | 2002 | 1141 | 0.130 |
Why?
|
| Estrogen Replacement Therapy | 5 | 2003 | 1209 | 0.130 |
Why?
|
| Disease Progression | 9 | 2016 | 13671 | 0.130 |
Why?
|
| Antipsychotic Agents | 4 | 2022 | 3081 | 0.130 |
Why?
|
| Hair Dyes | 1 | 1996 | 30 | 0.130 |
Why?
|
| Somatoform Disorders | 1 | 1999 | 425 | 0.130 |
Why?
|
| Cerebrovascular Disorders | 1 | 2003 | 1485 | 0.130 |
Why?
|
| Patient Satisfaction | 11 | 2012 | 3488 | 0.130 |
Why?
|
| Muscular Diseases | 4 | 1988 | 553 | 0.130 |
Why?
|
| Occupational Diseases | 2 | 1997 | 1457 | 0.130 |
Why?
|
| Schizophrenic Psychology | 2 | 2014 | 1649 | 0.130 |
Why?
|
| Hip Joint | 5 | 2010 | 1018 | 0.130 |
Why?
|
| Stomach Ulcer | 1 | 1996 | 118 | 0.130 |
Why?
|
| Follow-Up Studies | 25 | 2017 | 39348 | 0.130 |
Why?
|
| Violence | 1 | 2022 | 936 | 0.130 |
Why?
|
| North America | 4 | 2021 | 1289 | 0.120 |
Why?
|
| Bipolar Disorder | 2 | 2023 | 5130 | 0.120 |
Why?
|
| Health Promotion | 1 | 2007 | 2210 | 0.120 |
Why?
|
| Lyme Disease Vaccines | 2 | 2007 | 18 | 0.120 |
Why?
|
| Depressive Disorder, Major | 2 | 2023 | 4818 | 0.120 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2000 | 1140 | 0.120 |
Why?
|
| Atherosclerosis | 2 | 2008 | 3433 | 0.120 |
Why?
|
| Disabled Persons | 4 | 2000 | 1210 | 0.120 |
Why?
|
| Treatment Outcome | 30 | 2014 | 65371 | 0.120 |
Why?
|
| Pravastatin | 2 | 2007 | 393 | 0.110 |
Why?
|
| Social Class | 4 | 2001 | 2008 | 0.110 |
Why?
|
| Low Back Pain | 3 | 1998 | 990 | 0.110 |
Why?
|
| Physicians | 2 | 2011 | 4598 | 0.110 |
Why?
|
| Giant Cell Arteritis | 3 | 2011 | 307 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2004 | 1444 | 0.110 |
Why?
|
| Epidemiologic Methods | 2 | 1996 | 1328 | 0.110 |
Why?
|
| Rehabilitation, Vocational | 1 | 1993 | 70 | 0.110 |
Why?
|
| Home Care Services | 3 | 1986 | 659 | 0.110 |
Why?
|
| Schizophrenia | 4 | 2014 | 6983 | 0.110 |
Why?
|
| Massachusetts | 8 | 2007 | 8890 | 0.110 |
Why?
|
| Back | 1 | 1993 | 64 | 0.110 |
Why?
|
| Cohort Studies | 27 | 2010 | 41754 | 0.110 |
Why?
|
| Orthopedics | 4 | 2004 | 906 | 0.100 |
Why?
|
| Myocarditis | 1 | 2020 | 802 | 0.100 |
Why?
|
| Rehabilitation | 1 | 1994 | 129 | 0.100 |
Why?
|
| Diagnostic Tests, Routine | 1 | 1998 | 789 | 0.100 |
Why?
|
| Suicide, Attempted | 1 | 2022 | 1409 | 0.100 |
Why?
|
| DNA | 1 | 2006 | 7214 | 0.100 |
Why?
|
| Self-Assessment | 4 | 2000 | 400 | 0.100 |
Why?
|
| Travel | 1 | 2019 | 805 | 0.100 |
Why?
|
| Diagnosis-Related Groups | 3 | 2012 | 445 | 0.100 |
Why?
|
| Fibromyalgia | 1 | 1997 | 407 | 0.100 |
Why?
|
| Gastritis | 1 | 1994 | 199 | 0.100 |
Why?
|
| Prevalence | 12 | 2009 | 15869 | 0.100 |
Why?
|
| Reproducibility of Results | 20 | 2012 | 20227 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2024 | 1885 | 0.100 |
Why?
|
| Therapeutics | 1 | 1992 | 113 | 0.100 |
Why?
|
| Multivariate Analysis | 13 | 2017 | 12077 | 0.100 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2012 | 50 | 0.100 |
Why?
|
| Canada | 5 | 2010 | 2130 | 0.100 |
Why?
|
| Longitudinal Studies | 10 | 2017 | 14783 | 0.100 |
Why?
|
| Attitude to Health | 5 | 2007 | 2025 | 0.100 |
Why?
|
| Sex Distribution | 4 | 2009 | 2278 | 0.100 |
Why?
|
| Benchmarking | 3 | 2012 | 1057 | 0.100 |
Why?
|
| Preoperative Care | 3 | 1999 | 2258 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2012 | 1805 | 0.090 |
Why?
|
| Program Evaluation | 5 | 2009 | 2507 | 0.090 |
Why?
|
| Joint Diseases | 2 | 1998 | 461 | 0.090 |
Why?
|
| Bone Diseases | 2 | 1986 | 416 | 0.090 |
Why?
|
| Social Security | 1 | 1991 | 101 | 0.090 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2009 | 1741 | 0.090 |
Why?
|
| Length of Stay | 8 | 2016 | 6498 | 0.090 |
Why?
|
| Spondylitis | 1 | 1990 | 20 | 0.090 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 1991 | 64 | 0.090 |
Why?
|
| Contraceptives, Oral, Hormonal | 2 | 1989 | 190 | 0.090 |
Why?
|
| Incidence | 12 | 2017 | 21538 | 0.090 |
Why?
|
| Industry | 1 | 1993 | 362 | 0.090 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2003 | 319 | 0.090 |
Why?
|
| Breast Feeding | 2 | 2009 | 1363 | 0.090 |
Why?
|
| Cross-Sectional Studies | 11 | 2015 | 26379 | 0.090 |
Why?
|
| Aged, 80 and over | 25 | 2012 | 59629 | 0.090 |
Why?
|
| Spinal Fusion | 2 | 1997 | 1307 | 0.090 |
Why?
|
| Pain | 12 | 2000 | 5100 | 0.090 |
Why?
|
| Case Management | 1 | 2012 | 277 | 0.090 |
Why?
|
| Orthopedic Equipment | 1 | 1990 | 22 | 0.090 |
Why?
|
| Medical Audit | 1 | 1991 | 454 | 0.080 |
Why?
|
| Prospective Studies | 24 | 2017 | 54926 | 0.080 |
Why?
|
| Social Adjustment | 1 | 1992 | 635 | 0.080 |
Why?
|
| Prednisone | 2 | 2012 | 1567 | 0.080 |
Why?
|
| Cardiac Tamponade | 1 | 1991 | 175 | 0.080 |
Why?
|
| Hearing Aids | 1 | 1990 | 58 | 0.080 |
Why?
|
| Europe | 4 | 2017 | 3436 | 0.080 |
Why?
|
| Accidents, Occupational | 1 | 1991 | 251 | 0.080 |
Why?
|
| Chronic Disease | 6 | 2017 | 9384 | 0.080 |
Why?
|
| Linear Models | 5 | 2010 | 5884 | 0.080 |
Why?
|
| Self Care | 2 | 2012 | 799 | 0.080 |
Why?
|
| Patient Preference | 1 | 2016 | 946 | 0.080 |
Why?
|
| Health Literacy | 1 | 2014 | 466 | 0.080 |
Why?
|
| Time Factors | 16 | 2017 | 40218 | 0.080 |
Why?
|
| Boston | 9 | 2012 | 9374 | 0.080 |
Why?
|
| Retirement | 1 | 2010 | 198 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 3706 | 0.080 |
Why?
|
| Consumer Organizations | 1 | 2008 | 10 | 0.080 |
Why?
|
| Eyeglasses | 1 | 1990 | 138 | 0.080 |
Why?
|
| Predictive Value of Tests | 11 | 2020 | 15454 | 0.080 |
Why?
|
| Electronic Mail | 1 | 2010 | 215 | 0.080 |
Why?
|
| Radiography | 8 | 2009 | 6983 | 0.080 |
Why?
|
| Mammary Arteries | 1 | 2008 | 82 | 0.080 |
Why?
|
| Statistics as Topic | 7 | 1999 | 2357 | 0.080 |
Why?
|
| Exercise | 6 | 2003 | 5955 | 0.070 |
Why?
|
| Documentation | 2 | 2011 | 917 | 0.070 |
Why?
|
| Charities | 1 | 2008 | 35 | 0.070 |
Why?
|
| Social Support | 2 | 2001 | 2193 | 0.070 |
Why?
|
| Adolescent | 23 | 2017 | 89169 | 0.070 |
Why?
|
| Health Care Coalitions | 1 | 2007 | 36 | 0.070 |
Why?
|
| Physical Therapy Department, Hospital | 1 | 1987 | 4 | 0.070 |
Why?
|
| Locomotion | 2 | 1988 | 388 | 0.070 |
Why?
|
| Health Services | 2 | 2003 | 755 | 0.070 |
Why?
|
| Waist-Hip Ratio | 1 | 2009 | 520 | 0.070 |
Why?
|
| Anecdotes as Topic | 1 | 2007 | 56 | 0.070 |
Why?
|
| Disease Vectors | 1 | 2007 | 61 | 0.070 |
Why?
|
| Family Characteristics | 1 | 2012 | 1003 | 0.070 |
Why?
|
| Child Behavior Disorders | 1 | 1992 | 812 | 0.070 |
Why?
|
| Brachial Artery | 1 | 2009 | 373 | 0.070 |
Why?
|
| Prescriptions | 1 | 1990 | 388 | 0.070 |
Why?
|
| Research | 2 | 1993 | 1979 | 0.070 |
Why?
|
| Weight Gain | 1 | 2017 | 2359 | 0.070 |
Why?
|
| Prostheses and Implants | 1 | 1994 | 1276 | 0.070 |
Why?
|
| Life Style | 3 | 2010 | 3932 | 0.070 |
Why?
|
| Neuromuscular Diseases | 2 | 1994 | 260 | 0.070 |
Why?
|
| Range of Motion, Articular | 2 | 1995 | 1597 | 0.070 |
Why?
|
| History, 20th Century | 2 | 2007 | 2766 | 0.070 |
Why?
|
| Hospital Departments | 1 | 1987 | 135 | 0.070 |
Why?
|
| Disclosure | 1 | 1992 | 755 | 0.070 |
Why?
|
| Age Factors | 9 | 2019 | 18412 | 0.070 |
Why?
|
| Random Allocation | 4 | 1996 | 2396 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 1999 | 2257 | 0.070 |
Why?
|
| Injections, Intramuscular | 3 | 2014 | 556 | 0.070 |
Why?
|
| Anxiety | 2 | 2016 | 4672 | 0.070 |
Why?
|
| Culture | 1 | 2010 | 622 | 0.070 |
Why?
|
| Occupational Health | 1 | 1993 | 812 | 0.070 |
Why?
|
| Arthritis, Psoriatic | 1 | 2009 | 219 | 0.060 |
Why?
|
| Medical History Taking | 1 | 1990 | 779 | 0.060 |
Why?
|
| Informed Consent | 1 | 1992 | 1010 | 0.060 |
Why?
|
| Methotrexate | 2 | 2009 | 1721 | 0.060 |
Why?
|
| Arthroscopy | 1 | 1992 | 971 | 0.060 |
Why?
|
| Medical Order Entry Systems | 1 | 2011 | 524 | 0.060 |
Why?
|
| Workload | 1 | 2011 | 849 | 0.060 |
Why?
|
| Saphenous Vein | 1 | 2008 | 519 | 0.060 |
Why?
|
| Finger Joint | 1 | 2006 | 108 | 0.060 |
Why?
|
| Caribbean Region | 2 | 2012 | 193 | 0.060 |
Why?
|
| Lumbosacral Region | 3 | 1996 | 294 | 0.060 |
Why?
|
| Biopsy | 6 | 2017 | 6793 | 0.060 |
Why?
|
| Regional Blood Flow | 1 | 2009 | 1500 | 0.060 |
Why?
|
| Single-Blind Method | 4 | 2009 | 1587 | 0.060 |
Why?
|
| Blood Sedimentation | 1 | 1986 | 236 | 0.060 |
Why?
|
| Ramipril | 1 | 2005 | 102 | 0.060 |
Why?
|
| China | 3 | 2019 | 2395 | 0.060 |
Why?
|
| Altruism | 1 | 2007 | 211 | 0.060 |
Why?
|
| Waist Circumference | 1 | 2009 | 935 | 0.060 |
Why?
|
| Data Collection | 5 | 1996 | 3327 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 1993 | 1406 | 0.060 |
Why?
|
| Spondylitis, Ankylosing | 3 | 1994 | 159 | 0.060 |
Why?
|
| Vasodilation | 1 | 2009 | 967 | 0.060 |
Why?
|
| Costs and Cost Analysis | 6 | 2001 | 1667 | 0.060 |
Why?
|
| Consensus | 3 | 2020 | 3212 | 0.060 |
Why?
|
| Menopause | 3 | 1991 | 1656 | 0.060 |
Why?
|
| Wounds and Injuries | 2 | 1997 | 2517 | 0.060 |
Why?
|
| Cost of Illness | 2 | 2012 | 1951 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 1 | 1989 | 1363 | 0.060 |
Why?
|
| Borrelia burgdorferi Group | 2 | 2000 | 96 | 0.050 |
Why?
|
| Rosacea | 1 | 2004 | 60 | 0.050 |
Why?
|
| Mammaplasty | 1 | 1994 | 1268 | 0.050 |
Why?
|
| Birth Weight | 2 | 2009 | 2121 | 0.050 |
Why?
|
| Psychology | 2 | 2019 | 353 | 0.050 |
Why?
|
| Vitamin B Complex | 1 | 2005 | 299 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 587 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 1992 | 1668 | 0.050 |
Why?
|
| Reward | 1 | 2010 | 981 | 0.050 |
Why?
|
| Uric Acid | 2 | 2000 | 805 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 2 | 2003 | 598 | 0.050 |
Why?
|
| Adaptation, Psychological | 4 | 1993 | 2663 | 0.050 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2009 | 828 | 0.050 |
Why?
|
| Hypercholesterolemia | 2 | 2007 | 1145 | 0.050 |
Why?
|
| Self Concept | 2 | 2008 | 1043 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 1991 | 1162 | 0.050 |
Why?
|
| Coronary Artery Bypass | 2 | 2008 | 2191 | 0.050 |
Why?
|
| Ethics, Medical | 1 | 2007 | 785 | 0.050 |
Why?
|
| Hyperglycemia | 1 | 2011 | 1388 | 0.050 |
Why?
|
| Sex Factors | 7 | 2019 | 10632 | 0.050 |
Why?
|
| Spine | 4 | 1996 | 1140 | 0.050 |
Why?
|
| Administration, Oral | 5 | 2014 | 4030 | 0.050 |
Why?
|
| Focus Groups | 2 | 2007 | 1460 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2008 | 1110 | 0.050 |
Why?
|
| Point-of-Care Systems | 1 | 2011 | 1238 | 0.050 |
Why?
|
| Proportional Hazards Models | 6 | 2014 | 12543 | 0.050 |
Why?
|
| Body Surface Area | 2 | 2012 | 205 | 0.050 |
Why?
|
| Least-Squares Analysis | 2 | 2012 | 367 | 0.050 |
Why?
|
| Child | 17 | 2018 | 80917 | 0.050 |
Why?
|
| Probability | 3 | 2017 | 2479 | 0.050 |
Why?
|
| Methods | 3 | 1994 | 1066 | 0.050 |
Why?
|
| Alcoholic Beverages | 1 | 2023 | 266 | 0.050 |
Why?
|
| Interpersonal Relations | 4 | 2012 | 1434 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 2 | 2008 | 2709 | 0.050 |
Why?
|
| Contraceptives, Oral | 2 | 1997 | 560 | 0.050 |
Why?
|
| Pilot Projects | 4 | 2005 | 8741 | 0.050 |
Why?
|
| Age Distribution | 2 | 2009 | 2873 | 0.050 |
Why?
|
| Regression Analysis | 3 | 1999 | 6340 | 0.050 |
Why?
|
| Decision Support Techniques | 2 | 2009 | 2008 | 0.050 |
Why?
|
| Silicone Gels | 1 | 2001 | 39 | 0.050 |
Why?
|
| Workers' Compensation | 2 | 1992 | 150 | 0.050 |
Why?
|
| Postoperative Complications | 7 | 1996 | 15832 | 0.050 |
Why?
|
| Health Planning | 1 | 2002 | 233 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2007 | 741 | 0.050 |
Why?
|
| Insect Repellents | 1 | 2020 | 18 | 0.050 |
Why?
|
| Child, Preschool | 11 | 2016 | 42669 | 0.050 |
Why?
|
| Demography | 2 | 1997 | 1641 | 0.050 |
Why?
|
| Smoking | 6 | 2008 | 9092 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2007 | 1573 | 0.050 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2003 | 361 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 1991 | 2176 | 0.050 |
Why?
|
| Babesia | 1 | 2000 | 29 | 0.040 |
Why?
|
| Body Mass Index | 5 | 2017 | 13053 | 0.040 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2003 | 319 | 0.040 |
Why?
|
| Bone Density | 3 | 2000 | 3573 | 0.040 |
Why?
|
| Neoplasms | 3 | 2017 | 22371 | 0.040 |
Why?
|
| Infectious Disease Medicine | 1 | 2020 | 49 | 0.040 |
Why?
|
| Motor Activity | 1 | 2010 | 2711 | 0.040 |
Why?
|
| Obesity | 3 | 2017 | 13090 | 0.040 |
Why?
|
| California | 2 | 2002 | 1438 | 0.040 |
Why?
|
| Germany | 1 | 2002 | 883 | 0.040 |
Why?
|
| Consultants | 1 | 1980 | 57 | 0.040 |
Why?
|
| Anthropometry | 3 | 1990 | 1346 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2007 | 1514 | 0.040 |
Why?
|
| Physician's Role | 1 | 2007 | 925 | 0.040 |
Why?
|
| Mental Disorders | 3 | 2000 | 6874 | 0.040 |
Why?
|
| Gout | 3 | 2000 | 621 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 1991 | 1605 | 0.040 |
Why?
|
| Case-Control Studies | 7 | 2016 | 22291 | 0.040 |
Why?
|
| Homeostasis | 1 | 1991 | 3348 | 0.040 |
Why?
|
| Cardiovascular Diseases | 2 | 2017 | 15662 | 0.040 |
Why?
|
| Babesiosis | 1 | 2000 | 92 | 0.040 |
Why?
|
| Comorbidity | 3 | 2003 | 10590 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2007 | 983 | 0.040 |
Why?
|
| Aorta | 1 | 2007 | 2045 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2010 | 2907 | 0.040 |
Why?
|
| Likelihood Functions | 2 | 1995 | 994 | 0.040 |
Why?
|
| Markov Chains | 1 | 2003 | 979 | 0.040 |
Why?
|
| Polymyalgia Rheumatica | 2 | 2011 | 52 | 0.040 |
Why?
|
| Employment | 3 | 1991 | 1110 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2011 | 2187 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2011 | 10760 | 0.040 |
Why?
|
| Young Adult | 9 | 2019 | 60066 | 0.040 |
Why?
|
| Registries | 2 | 2012 | 8375 | 0.040 |
Why?
|
| Environmental Exposure | 2 | 2007 | 4543 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2006 | 6316 | 0.040 |
Why?
|
| Postoperative Period | 3 | 2002 | 1826 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2008 | 2124 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2020 | 382 | 0.040 |
Why?
|
| Medicare | 2 | 1998 | 6809 | 0.040 |
Why?
|
| Medical Records | 3 | 2003 | 1410 | 0.040 |
Why?
|
| Psychotic Disorders | 1 | 2014 | 3276 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2009 | 4352 | 0.040 |
Why?
|
| Anticholesteremic Agents | 1 | 2005 | 972 | 0.040 |
Why?
|
| Paraproteinemias | 1 | 2001 | 252 | 0.040 |
Why?
|
| Reference Values | 3 | 2017 | 4938 | 0.040 |
Why?
|
| Coronary Artery Disease | 2 | 2008 | 6568 | 0.040 |
Why?
|
| Models, Theoretical | 4 | 1995 | 3573 | 0.040 |
Why?
|
| Sampling Studies | 1 | 1999 | 615 | 0.040 |
Why?
|
| Antimanic Agents | 1 | 2022 | 524 | 0.040 |
Why?
|
| Child Welfare | 1 | 2002 | 523 | 0.040 |
Why?
|
| Referral and Consultation | 2 | 2009 | 3620 | 0.040 |
Why?
|
| Calcium | 1 | 1991 | 5792 | 0.040 |
Why?
|
| Anaphylaxis | 2 | 1999 | 758 | 0.040 |
Why?
|
| Lead Poisoning | 1 | 2000 | 323 | 0.040 |
Why?
|
| Animals | 8 | 2021 | 169246 | 0.040 |
Why?
|
| Antibodies, Bacterial | 2 | 2020 | 1479 | 0.040 |
Why?
|
| Amoxicillin | 1 | 1998 | 182 | 0.040 |
Why?
|
| Odds Ratio | 4 | 2008 | 9669 | 0.040 |
Why?
|
| Depression | 5 | 2023 | 8230 | 0.040 |
Why?
|
| Premature Birth | 1 | 2009 | 1829 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 3252 | 0.030 |
Why?
|
| Delayed-Action Preparations | 2 | 2011 | 969 | 0.030 |
Why?
|
| Ethanol | 1 | 2023 | 1331 | 0.030 |
Why?
|
| Motivation | 1 | 2007 | 2020 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2012 | 4530 | 0.030 |
Why?
|
| Insurance Claim Reporting | 1 | 1997 | 166 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4427 | 0.030 |
Why?
|
| Confidence Intervals | 2 | 1995 | 2923 | 0.030 |
Why?
|
| Sick Leave | 1 | 1997 | 105 | 0.030 |
Why?
|
| Work | 1 | 1997 | 195 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2020 | 881 | 0.030 |
Why?
|
| Patient Compliance | 3 | 2011 | 2697 | 0.030 |
Why?
|
| Hydroxychloroquine | 1 | 2000 | 426 | 0.030 |
Why?
|
| Observer Variation | 1 | 2002 | 2622 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2009 | 2538 | 0.030 |
Why?
|
| Insulin | 1 | 2011 | 6607 | 0.030 |
Why?
|
| Risk | 5 | 2009 | 9613 | 0.030 |
Why?
|
| Immune System Diseases | 1 | 1999 | 253 | 0.030 |
Why?
|
| Africa | 1 | 1998 | 725 | 0.030 |
Why?
|
| Medicare Part B | 1 | 1997 | 116 | 0.030 |
Why?
|
| Occupational Health Services | 1 | 1997 | 149 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 1998 | 175 | 0.030 |
Why?
|
| Endemic Diseases | 1 | 1997 | 191 | 0.030 |
Why?
|
| Musculoskeletal System | 1 | 1998 | 188 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 2029 | 0.030 |
Why?
|
| Motor Skills Disorders | 1 | 2016 | 89 | 0.030 |
Why?
|
| Neuropsychological Tests | 3 | 2007 | 7140 | 0.030 |
Why?
|
| Tunica Intima | 2 | 2008 | 459 | 0.030 |
Why?
|
| Arthralgia | 1 | 1999 | 459 | 0.030 |
Why?
|
| Self-Help Devices | 2 | 1988 | 62 | 0.030 |
Why?
|
| Alcohol Drinking | 3 | 2023 | 4045 | 0.030 |
Why?
|
| Selection Bias | 1 | 1997 | 360 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 2 | 2011 | 714 | 0.030 |
Why?
|
| Reoperation | 3 | 1999 | 4329 | 0.030 |
Why?
|
| Penicillins | 1 | 1998 | 406 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2009 | 6283 | 0.030 |
Why?
|
| Patient Admission | 1 | 2002 | 1365 | 0.030 |
Why?
|
| Exercise Test | 2 | 1995 | 2186 | 0.030 |
Why?
|
| Silver Staining | 1 | 1994 | 63 | 0.030 |
Why?
|
| Language Development Disorders | 1 | 2016 | 194 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2019 | 825 | 0.030 |
Why?
|
| Drug Costs | 1 | 2003 | 1195 | 0.030 |
Why?
|
| Risk Assessment | 5 | 2020 | 24315 | 0.030 |
Why?
|
| Retinal Diseases | 1 | 2000 | 710 | 0.030 |
Why?
|
| Lead | 1 | 2000 | 882 | 0.030 |
Why?
|
| Vocational Guidance | 1 | 1993 | 14 | 0.030 |
Why?
|
| Ovary | 1 | 1999 | 965 | 0.030 |
Why?
|
| Suburban Population | 1 | 1994 | 54 | 0.030 |
Why?
|
| Veterans | 2 | 2022 | 2669 | 0.030 |
Why?
|
| Arthritis, Gouty | 1 | 1994 | 28 | 0.030 |
Why?
|
| Gold | 1 | 1978 | 488 | 0.030 |
Why?
|
| Algorithms | 1 | 2014 | 14164 | 0.030 |
Why?
|
| Attitude | 1 | 2019 | 771 | 0.030 |
Why?
|
| Aspirin | 1 | 2005 | 3135 | 0.030 |
Why?
|
| Logistic Models | 3 | 2003 | 13290 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 4568 | 0.030 |
Why?
|
| Public Health | 1 | 2007 | 2679 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1998 | 747 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 1999 | 964 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2017 | 1049 | 0.030 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 1992 | 62 | 0.030 |
Why?
|
| Physical Endurance | 1 | 1995 | 369 | 0.030 |
Why?
|
| Infant | 6 | 2012 | 36535 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 1999 | 1443 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 1999 | 2227 | 0.030 |
Why?
|
| Vermont | 1 | 1992 | 80 | 0.030 |
Why?
|
| Barbados | 1 | 2012 | 52 | 0.030 |
Why?
|
| Brain | 1 | 2000 | 27360 | 0.030 |
Why?
|
| Pruritus | 1 | 2016 | 379 | 0.030 |
Why?
|
| Taiwan | 1 | 1994 | 521 | 0.030 |
Why?
|
| Interviews as Topic | 2 | 2011 | 2741 | 0.030 |
Why?
|
| Memory Disorders | 1 | 1999 | 1200 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2017 | 4978 | 0.030 |
Why?
|
| Hospitals, Private | 1 | 2012 | 67 | 0.020 |
Why?
|
| Minnesota | 1 | 1993 | 339 | 0.020 |
Why?
|
| Social Behavior | 1 | 2019 | 1147 | 0.020 |
Why?
|
| Biometry | 1 | 1995 | 570 | 0.020 |
Why?
|
| Thrombophlebitis | 1 | 1992 | 289 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 3251 | 0.020 |
Why?
|
| Fish Oils | 1 | 1995 | 483 | 0.020 |
Why?
|
| Social Behavior Disorders | 1 | 1992 | 100 | 0.020 |
Why?
|
| Motor Skills | 1 | 1995 | 523 | 0.020 |
Why?
|
| Risk-Taking | 1 | 1997 | 1023 | 0.020 |
Why?
|
| Walking | 2 | 1996 | 1201 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2007 | 3463 | 0.020 |
Why?
|
| Sweden | 1 | 1994 | 1382 | 0.020 |
Why?
|
| Work Capacity Evaluation | 1 | 1991 | 42 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2022 | 1462 | 0.020 |
Why?
|
| Retrospective Studies | 11 | 2001 | 81762 | 0.020 |
Why?
|
| Skin Diseases | 2 | 2016 | 1085 | 0.020 |
Why?
|
| Fees and Charges | 1 | 2012 | 189 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 1990 | 6229 | 0.020 |
Why?
|
| Hospital Costs | 1 | 1997 | 957 | 0.020 |
Why?
|
| Urban Population | 2 | 1994 | 2046 | 0.020 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1990 | 113 | 0.020 |
Why?
|
| Pain Measurement | 3 | 2002 | 3583 | 0.020 |
Why?
|
| Personnel Selection | 1 | 1992 | 201 | 0.020 |
Why?
|
| Osteocalcin | 1 | 1991 | 275 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2004 | 5919 | 0.020 |
Why?
|
| Thorax | 2 | 1990 | 557 | 0.020 |
Why?
|
| Leg | 1 | 1995 | 1088 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1978 | 1798 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2011 | 416 | 0.020 |
Why?
|
| Paresthesia | 1 | 1990 | 160 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2022 | 12465 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 1001 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 3728 | 0.020 |
Why?
|
| Minerals | 1 | 1991 | 282 | 0.020 |
Why?
|
| Shoes | 1 | 1990 | 91 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 948 | 0.020 |
Why?
|
| Self Disclosure | 1 | 1990 | 248 | 0.020 |
Why?
|
| Reference Standards | 1 | 1993 | 1014 | 0.020 |
Why?
|
| Wrist | 1 | 1990 | 231 | 0.020 |
Why?
|
| Internal Medicine | 1 | 1976 | 1064 | 0.020 |
Why?
|
| Orthotic Devices | 1 | 1990 | 131 | 0.020 |
Why?
|
| Sensation | 1 | 1990 | 336 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 9263 | 0.020 |
Why?
|
| Teaching | 1 | 1976 | 1171 | 0.020 |
Why?
|
| Telephone | 1 | 2012 | 630 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2011 | 395 | 0.020 |
Why?
|
| Neural Conduction | 1 | 1990 | 443 | 0.020 |
Why?
|
| Salaries and Fringe Benefits | 1 | 1991 | 263 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2003 | 7876 | 0.020 |
Why?
|
| Truth Disclosure | 1 | 1992 | 434 | 0.020 |
Why?
|
| Self Efficacy | 2 | 2004 | 643 | 0.020 |
Why?
|
| Immune System | 1 | 1994 | 799 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 5889 | 0.020 |
Why?
|
| Osteitis Deformans | 1 | 1988 | 54 | 0.020 |
Why?
|
| Behavior | 1 | 1991 | 542 | 0.020 |
Why?
|
| Prognosis | 4 | 2001 | 30010 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 1998 | 1765 | 0.020 |
Why?
|
| Confidentiality | 1 | 2012 | 607 | 0.020 |
Why?
|
| Psychiatry | 1 | 1980 | 1716 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2010 | 534 | 0.020 |
Why?
|
| Pleural Effusion | 1 | 1991 | 344 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1990 | 1266 | 0.020 |
Why?
|
| Spondylarthritis | 1 | 2008 | 62 | 0.020 |
Why?
|
| Edema | 1 | 1991 | 765 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 1990 | 914 | 0.020 |
Why?
|
| Manometry | 1 | 2009 | 459 | 0.020 |
Why?
|
| Health Resources | 1 | 1992 | 950 | 0.020 |
Why?
|
| Neck Pain | 1 | 2008 | 191 | 0.020 |
Why?
|
| Mortality | 1 | 2017 | 2911 | 0.020 |
Why?
|
| Sjogren's Syndrome | 1 | 2008 | 240 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 1991 | 829 | 0.020 |
Why?
|
| Reproduction | 1 | 1990 | 646 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4860 | 0.020 |
Why?
|
| Gait | 1 | 1991 | 823 | 0.020 |
Why?
|
| Colchicine | 1 | 1987 | 257 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2013 | 6029 | 0.020 |
Why?
|
| Physical Exertion | 1 | 1988 | 668 | 0.020 |
Why?
|
| Hand | 1 | 1990 | 913 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 1997 | 7852 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2007 | 425 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1998 | 2819 | 0.010 |
Why?
|
| Face | 1 | 1991 | 1029 | 0.010 |
Why?
|
| Syndrome | 1 | 1991 | 3272 | 0.010 |
Why?
|
| Femur | 1 | 1991 | 1321 | 0.010 |
Why?
|
| Dementia | 2 | 1998 | 2740 | 0.010 |
Why?
|
| Physical Therapy Modalities | 2 | 1989 | 533 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1991 | 1804 | 0.010 |
Why?
|
| Primary Health Care | 2 | 1982 | 4746 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 1988 | 696 | 0.010 |
Why?
|
| Somatosensory Cortex | 1 | 2008 | 516 | 0.010 |
Why?
|
| Scleroderma, Systemic | 1 | 2008 | 346 | 0.010 |
Why?
|
| Adolescent Behavior | 1 | 1992 | 1186 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1986 | 963 | 0.010 |
Why?
|
| Recurrence | 2 | 1998 | 8509 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1989 | 1880 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 2008 | 26422 | 0.010 |
Why?
|
| Rural Population | 1 | 1994 | 2325 | 0.010 |
Why?
|
| Mental Health | 2 | 2000 | 3275 | 0.010 |
Why?
|
| Kidney | 1 | 1978 | 7064 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2007 | 1760 | 0.010 |
Why?
|
| Family | 2 | 1992 | 3209 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 1886 | 0.010 |
Why?
|
| Recreation | 1 | 2003 | 124 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 13014 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1989 | 1281 | 0.010 |
Why?
|
| History, 15th Century | 1 | 1981 | 29 | 0.010 |
Why?
|
| Injections, Intravenous | 2 | 1998 | 1377 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1984 | 643 | 0.010 |
Why?
|
| Health Policy | 1 | 1994 | 2698 | 0.010 |
Why?
|
| Cause of Death | 1 | 2012 | 3721 | 0.010 |
Why?
|
| Educational Status | 1 | 2009 | 2515 | 0.010 |
Why?
|
| Professional Practice | 1 | 2003 | 314 | 0.010 |
Why?
|
| Fibrosis | 1 | 2008 | 2080 | 0.010 |
Why?
|
| Motion | 1 | 1985 | 790 | 0.010 |
Why?
|
| Age of Onset | 1 | 2008 | 3347 | 0.010 |
Why?
|
| Depressive Disorder | 2 | 1992 | 3721 | 0.010 |
Why?
|
| Publishing | 1 | 1988 | 837 | 0.010 |
Why?
|
| Movement | 1 | 1988 | 1490 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2001 | 283 | 0.010 |
Why?
|
| ROC Curve | 1 | 2009 | 3628 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 1996 | 4310 | 0.010 |
Why?
|
| Pregnancy | 3 | 2009 | 30256 | 0.010 |
Why?
|
| Hospitals | 1 | 1994 | 3886 | 0.010 |
Why?
|
| Body Weight | 1 | 2011 | 4627 | 0.010 |
Why?
|
| Calcinosis | 1 | 2008 | 1481 | 0.010 |
Why?
|
| Reimbursement Mechanisms | 1 | 1985 | 670 | 0.010 |
Why?
|
| Color Perception | 1 | 2000 | 212 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 1992 | 3007 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2010 | 5315 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1992 | 2599 | 0.010 |
Why?
|
| Histamine H1 Antagonists | 1 | 1999 | 101 | 0.010 |
Why?
|
| Virginia | 1 | 1998 | 115 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 1992 | 3929 | 0.010 |
Why?
|
| Vulnerable Populations | 1 | 2004 | 718 | 0.010 |
Why?
|
| Osteoporosis | 1 | 1988 | 1605 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1978 | 189 | 0.010 |
Why?
|
| Colorado | 1 | 1998 | 167 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 1980 | 342 | 0.010 |
Why?
|
| Inflammation | 2 | 2009 | 10873 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1986 | 1384 | 0.010 |
Why?
|
| Inhalation | 1 | 1998 | 145 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12840 | 0.010 |
Why?
|
| Heart Rate | 1 | 1989 | 4214 | 0.010 |
Why?
|
| Agranulocytosis | 1 | 1978 | 98 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1320 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1999 | 347 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2007 | 2403 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 2000 | 458 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 4423 | 0.010 |
Why?
|
| Leuprolide | 1 | 1999 | 313 | 0.010 |
Why?
|
| Food Hypersensitivity | 2 | 1999 | 734 | 0.010 |
Why?
|
| Delirium | 1 | 1989 | 1697 | 0.010 |
Why?
|
| Role | 1 | 1997 | 176 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2011 | 3288 | 0.010 |
Why?
|
| Hematuria | 1 | 1978 | 232 | 0.010 |
Why?
|
| District of Columbia | 1 | 1976 | 159 | 0.010 |
Why?
|
| Counseling | 1 | 2004 | 1554 | 0.010 |
Why?
|
| Internship and Residency | 1 | 1976 | 5953 | 0.010 |
Why?
|
| Lower Extremity | 1 | 2004 | 1216 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 1988 | 2420 | 0.010 |
Why?
|
| Fear | 3 | 1997 | 1495 | 0.010 |
Why?
|
| Epinephrine | 1 | 1999 | 794 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2009 | 6004 | 0.010 |
Why?
|
| Personality Disorders | 1 | 1980 | 726 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1995 | 222 | 0.010 |
Why?
|
| Injections | 1 | 1998 | 840 | 0.010 |
Why?
|
| Cost Control | 1 | 1978 | 627 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1986 | 4912 | 0.010 |
Why?
|
| Hospitals, Military | 1 | 1975 | 62 | 0.010 |
Why?
|
| Amenorrhea | 1 | 1999 | 484 | 0.010 |
Why?
|
| Electrocardiography | 2 | 1998 | 6412 | 0.010 |
Why?
|
| Proteinuria | 1 | 1978 | 611 | 0.010 |
Why?
|
| Creatinine | 1 | 2000 | 1918 | 0.010 |
Why?
|
| Office Visits | 1 | 1998 | 595 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1999 | 1737 | 0.010 |
Why?
|
| Ophthalmology | 1 | 2000 | 560 | 0.010 |
Why?
|
| Kidney Calculi | 1 | 1978 | 458 | 0.010 |
Why?
|
| Hospitals, Public | 1 | 1975 | 204 | 0.010 |
Why?
|
| Joints | 1 | 1995 | 324 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2011 | 4887 | 0.010 |
Why?
|
| Nurse Practitioners | 1 | 1976 | 271 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 12252 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1975 | 392 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1999 | 1149 | 0.010 |
Why?
|
| Child Behavior | 1 | 1998 | 864 | 0.010 |
Why?
|
| Physician Assistants | 1 | 1975 | 190 | 0.010 |
Why?
|
| Hand Strength | 1 | 1995 | 466 | 0.010 |
Why?
|
| Computers | 1 | 1994 | 592 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2002 | 2981 | 0.010 |
Why?
|
| Emotions | 1 | 1984 | 2767 | 0.010 |
Why?
|
| Pediatrics | 1 | 2007 | 3629 | 0.010 |
Why?
|
| Acute Disease | 1 | 1982 | 7243 | 0.010 |
Why?
|
| Cognition | 1 | 2008 | 7073 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 1978 | 1179 | 0.010 |
Why?
|
| Flurazepam | 1 | 1989 | 8 | 0.010 |
Why?
|
| Jogging | 1 | 1989 | 18 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 1995 | 2107 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2000 | 2100 | 0.000 |
Why?
|
| Scopolamine | 1 | 1989 | 93 | 0.000 |
Why?
|
| Cross-Cultural Comparison | 1 | 1992 | 638 | 0.000 |
Why?
|
| Information Systems | 1 | 1989 | 400 | 0.000 |
Why?
|
| Menarche | 1 | 1990 | 538 | 0.000 |
Why?
|
| Rotation | 1 | 1989 | 517 | 0.000 |
Why?
|
| Propranolol | 1 | 1989 | 493 | 0.000 |
Why?
|
| Parity | 1 | 1990 | 931 | 0.000 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1989 | 349 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 3814 | 0.000 |
Why?
|
| Pregnancy Complications | 1 | 1999 | 2973 | 0.000 |
Why?
|
| Caregivers | 1 | 1997 | 2302 | 0.000 |
Why?
|
| Health Expenditures | 1 | 1997 | 2389 | 0.000 |
Why?
|
| Hypertension | 1 | 2004 | 8616 | 0.000 |
Why?
|
| Blood Pressure | 1 | 2000 | 8543 | 0.000 |
Why?
|
| Neck | 1 | 1989 | 736 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 3447 | 0.000 |
Why?
|
| C-Reactive Protein | 1 | 1995 | 3858 | 0.000 |
Why?
|
| Curriculum | 1 | 1976 | 3782 | 0.000 |
Why?
|
| Body Height | 1 | 1989 | 1565 | 0.000 |
Why?
|
| Sick Role | 1 | 1982 | 229 | 0.000 |
Why?
|
| Neutropenia | 1 | 1987 | 892 | 0.000 |
Why?
|
| Phobic Disorders | 1 | 1982 | 441 | 0.000 |
Why?
|
| Triage | 1 | 1975 | 997 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1975 | 2783 | 0.000 |
Why?
|